BECTON, DICKINSON AND COMPANY for BECTON DICKINSON AND COMPANY
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
NIH funding Global health funding CDC funding
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANNY LY | — |
Consumer Issues/Safety/Products CSP
Issues related to data privacy
| Lobbyist | Covered position, as disclosed |
|---|---|
| ADAM LOTSPIKE | — |
| TODD SPANGLER | — |
Taxation/Internal Revenue Code TAX
H.R.2207, Protect Medical Innovation Act of 2019, repeal of the medical device tax S.692, Protect Medical Innovation Act of 2019, repeal of the medical device tax
| Lobbyist | Covered position, as disclosed |
|---|---|
| JESSICA JOHNSTON | — |
| ADAM LOTSPIKE New | — |
| DANNY LY | — |
| TODD SPANGLER | — |
| ELIZABETH WOODY | — |
Health Issues HCR
Issues related to medication safety and drug diversion Issues related to device cyber security Issues related to Veterans Affairs procurement of medical devices Issues related to medical device sterilization Issues related to hazardous drug safety Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to end-stage renal disease devices
| Lobbyist | Covered position, as disclosed |
|---|---|
| JESSICA JOHNSTON | — |
| ADAM LOTSPIKE New | — |
| DANNY LY | — |
| TODD SPANGLER | — |
| ELIZABETH WOODY | — |
Trade (domestic/foreign) TRD
China tariffs Steel aluminum tariffs
| Lobbyist | Covered position, as disclosed |
|---|---|
| TODD SPANGLER | — |
| ELIZABETH WOODY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.